Jennifer Arnold is Co-Founder and COO of Altro Health, a clinical infrastructure platform empowering wellness businesses to offer medical-grade services including peptides, GLP-1s, hormone therapy, and lab testing under their own brand.

Jennifer is a biomedical engineer from Duke University who earned her MS/MBA from Harvard Business School, where she co-led the women's health group, and previously served as COO and then President and CEO of medtech company Transit Scientific.

Jennifer was recognized as one of the Most Inspiring Women in Technology 2024 by the World Future Awards for her contributions to healthcare innovation, women's health, longevity, and AI.

Prior to Altro Health, Jennifer and co-founder Andrea Corleto built Lyv Health, a virtual longevity clinic for women offering coaching, lab testing, hormone therapy, and nutrition support, which became the proving ground for the Altro platform.

Altro Health has raised $7M in seed funding led by NFX, onboarded over 500 fitness operators, medspas, and longevity clubs, and is targeting the $47 billion longevity market as its clinical operating layer.